{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:17Z","timestamp":1794565577120,"version":"4.9.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003038","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:05:19Z","timestamp":1461330319000},"page":"e3038","source":"Crossref","is-referenced-by-count":74,"title":["A Laboratory Phenotype\/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease"],"prefix":"10.1097","volume":"95","author":[{"given":"Agn\u00e8s","family":"Veyradier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boisseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ternisien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Zawadzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Trossaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Itzhar-Ba\u00efkian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"d\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Borel-Derlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bezieau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile V.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goudemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20210226","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood-2013-02-482000","article-title":"Von Willebrand factor in its native environment","volume":"121","author":"Sadler","year":"2013","journal-title":"Blood"},{"key":"R2-30-20210226","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"key":"R3-30-20210226","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"Von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"key":"R4-30-20210226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"key":"R5-30-20210226","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/GIM.0b013e3182035931","article-title":"Von Willebrand disease","volume":"13","author":"James","year":"2011","journal-title":"Genet Med"},{"key":"R6-30-20210226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.56.082103.104713","article-title":"New concepts in von Willebrand disease","volume":"56","author":"Sadler","year":"2005","journal-title":"Annu Rev Med"},{"key":"R7-30-20210226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0033-1334867","article-title":"Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update","volume":"39","author":"Federici","year":"2013","journal-title":"Semin Thromb Haemost"},{"key":"R8-30-20210226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors\u2019 Organisation guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"R9-30-20210226","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R10-30-20210226","first-page":"112","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease.","volume":"106-","author":"Sadler","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R11-30-20210226","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"R12-30-20210226","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"key":"R13-30-20210226","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood-2014-08-551960","article-title":"How I treat type 2 variant forms of von Willebrand disease","volume":"125","author":"Tosetto","year":"2015","journal-title":"Blood"},{"key":"R14-30-20210226","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS13 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"key":"R15-30-20210226","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1538-7836.2008.02941.x","article-title":"Prevalence of type 2B \u201cMalm\u00f6\/New York\u201d von Willebrand disease in Italy: the role of von Willebrand factor gene conversion","volume":"6","author":"Baronciani","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R16-30-20210226","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1538-7836.2010.03753.x","article-title":"Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza","volume":"8","author":"Gezsi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R17-30-20210226","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"key":"R18-30-20210226","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/asheducation-2013.1.254","article-title":"Von Willebrand disease: advances in pathogenic understanding, diagnosis, and therapy","volume":"2013","author":"Lillicrap","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R19-30-20210226","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"MCMDM-1VWD Study Group. VWF propeptide and ratios between VWF, VWF propeptide, and the FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"key":"R20-30-20210226","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R21-30-20210226","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/hae.12409","article-title":"Genetic testing in bleeding disorders","volume":"20","author":"De Brasi","year":"2014","journal-title":"Haemophilia"},{"key":"R22-30-20210226","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-2516.2008.01813.x","article-title":"The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors\u2019 Organisation Haemophilia Genetics Laboratory Network","volume":"14","author":"Keeney","year":"2008","journal-title":"Haemophilia"},{"key":"R23-30-20210226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0033-1364182","article-title":"Platelet-type von Willebrand disease: toward an improved understanding of the \u201csticky situation\u201d","volume":"40","author":"Othman","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"R24-30-20210226","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and the phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1 VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"key":"R25-30-20210226","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"R26-30-20210226","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"R27-30-20210226","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"R28-30-20210226","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R29-30-20210226","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.2006.06095.x","article-title":"Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performance in patients with type 2B von Willebrand disease","volume":"133","author":"Caron","year":"2006","journal-title":"Br J Haematol"},{"key":"R30-30-20210226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1613768","article-title":"Collagen binding assay for von Willebrand factor (VWF: CBA): detection of von Willebrand disease (VWD) and discrimination of VWD subtypes, depends on collagen source","volume":"83","author":"Favaloro","year":"2000","journal-title":"Thromb Haemost"},{"key":"R31-30-20210226","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.2002.03488.x","article-title":"Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents","volume":"117","author":"Caron","year":"2002","journal-title":"Br J Haematol"},{"key":"R32-30-20210226","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"R33-30-20210226","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1182\/blood-2014-02-557264","article-title":"The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease","volume":"123","author":"Federici","year":"2014","journal-title":"Blood"},{"key":"R34-30-20210226","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0031-1281038","article-title":"The diagnosis and management of von Willebrand disease in Canada","volume":"37","author":"James","year":"2011","journal-title":"Semin Thromb Haemost"},{"key":"R35-30-20210226","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0031-1281039","article-title":"Von Willebrand disease in the United States: a perspective from Wisconsin","volume":"37","author":"Flood","year":"2011","journal-title":"Semin Thromb Haemost"},{"key":"R36-30-20210226","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH12-02-0089","article-title":"Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients","volume":"108","author":"Yadegari","year":"2012","journal-title":"Thromb Haemost"},{"key":"R37-30-20210226","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"WIN study group. Von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"key":"R39-30-20210226","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"Association of Hemophilia Clinic Directors of Canada. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R40-30-20210226","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"key":"R41-30-20210226","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/ajh.23265","article-title":"Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: studies of an Italian cohort of 10 patients","volume":"87","author":"Solimando","year":"2012","journal-title":"Am J Hematol"},{"key":"R42-30-20210226","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1365-2516.2009.02046.x","article-title":"Molecular characterization of Iranian patients with type 3 von Willebrand disease","volume":"15","author":"Shahbazi","year":"2009","journal-title":"Haemophilia"},{"key":"R43-30-20210226","doi-asserted-by":"crossref","first-page":"e92575","DOI":"10.1371\/journal.pone.0092575","article-title":"Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients","volume":"9","author":"Kasatkar","year":"2014","journal-title":"PLoS One"},{"key":"R45-30-20210226","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2009.03486.x","article-title":"Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study","volume":"7","author":"Eikenboom","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R46-30-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1538-7836.2007.02488.x","article-title":"Type 1 von Willebrand disease","volume":"5","author":"Peake","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R47-30-20210226","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-08-173278","article-title":"A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3","volume":"114","author":"Sutherland","year":"2009","journal-title":"Blood"},{"key":"R48-30-20210226","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-06-506147","article-title":"VWF sequence variants: a data goldmine","volume":"122","author":"Goodeve","year":"2013","journal-title":"Blood"},{"key":"R49-30-20210226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1160\/TH12-07-0475","article-title":"Characterisation of mutations and molecular studies of type 2 von Willebrand disease","volume":"109","author":"Ahmad","year":"2013","journal-title":"Thromb Haemost"},{"key":"R50-30-20210226","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1657568","article-title":"Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM network on molecular abnormalities in von Willebrand disease","volume":"78","author":"Meyer","year":"1997","journal-title":"Thromb Haemost"},{"key":"R52-30-20210226","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood"},{"key":"R53-30-20210226","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2009-07-231886","article-title":"Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B","volume":"115","author":"Nurden","year":"2010","journal-title":"Blood"},{"key":"R54-30-20210226","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R55-30-20210226","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"R56-30-20210226","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3324\/haematol.2011.046623","article-title":"The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked","volume":"96","author":"Hampshire","year":"2011","journal-title":"Haematologica"},{"key":"R57-30-20210226","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/asheducation.V2014.1.531.3883265","article-title":"New insights into genotype and phenotype of VWD","volume":"2014","author":"Flood","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:19:34Z","timestamp":1620958774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603150-00030"}},"subtitle":["A New Epidemiologic Picture"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003038","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}